Insider Trading Activity For Magellan Health, Inc. (NASDAQ:MGLN)
Daniel N Gregoire , General Counsel of Magellan Health, Inc. (NASDAQ:MGLN) reportedly Sold 33,574 shares of the company’s stock at an average price of 80.11 for a total transaction amount of $2,689,613.14 SEC Form
Insider Trading History For Magellan Health, Inc. (NASDAQ:MGLN)
Analyst Ratings For Magellan Health, Inc. (NASDAQ:MGLN)
These are 1 Sell Rating, 3 Buy Ratings .
The current consensus rating for Magellan Health, Inc. (NASDAQ:MGLN) is Buy (Score: 2.50) with a consensus target price of $80.25 , a potential (1.23% downside)
Analyst Ratings History For Magellan Health, Inc. (NASDAQ:MGLN)
- On 11/23/2016 Barclays PLC Boost Price Target of rating Underweight with a price target of $61.00 to $69.00
- On 2/24/2017 Jefferies Group LLC Lower Price Target of rating Buy with a price target of $89.00 to $88.00
- On 6/25/2017 Leerink Swann Reiterated Rating Outperform with a price target of $68.00 to $73.00
- On 7/13/2017 KeyCorp Upgraded rating Sector Weight to Overweight with a price target of $91.00
Recent Trading Activity for Magellan Health, Inc. (NASDAQ:MGLN)
Shares of Magellan Health, Inc. closed the previous trading session at 81.25 up +1.00 1.25% with 251,415 shares trading hands.